RECENT FUNDING
  1. Recent Funding
  2. Investors
  3. TAS Partners
T

TAS Partners portfolio

TAS Partners has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.

Type: Investor.
Portfolio on Recent Funding: 1.
Deals, last 12 months: 1.
Capital in their rounds: $135M.
Latest deal: Soufflé Therapeutics · Oct 13, 2026.
About this page

Its most recent investment on record is Soufflé Therapeutics's $135M Series B+ round in October 2026, alongside Leaps by Bayer, Vida Ventures, Janus Henderson Investors and 6 others. That company is in Health and bio.

What TAS Partners invests in

How TAS Partners invests

StageDealsCapital in rounds
Series B+ 1 100%$135M

TAS Partners portfolio companies

CompanyRound with TAS PartnersTotal raisedLatest raise
SSoufflé Therapeutics
Health and bio
 Series B+ · $135M$335MOct 13, 2026
Series B+

Most frequent co-investors

Similar investors

Investors whose portfolios on Recent Funding center on the same category (Health and bio).

How this is counted

Share is of the 1 round on Recent Funding that name TAS Partners. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.

Portfolio companies are the companies on Recent Funding with a round that lists TAS Partners, which is a subset of its real portfolio. API: /api/v1/investors/tas-partners (get a free API key). More: the most active VC firms and new venture capital funds.